Bio-Rad Laboratories ROA 2006-2019 | BIO

Current and historical return on assets (ROA) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Bio-Rad Laboratories ROA for the three months ending June 30, 2019 was 2.81%.
Bio-Rad Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $0.90B $7.65B 13.47%
2019-03-31 $0.57B $6.86B 8.96%
2018-12-31 $0.37B $5.61B 5.86%
2018-09-30 $1.28B $6.72B 21.65%
2018-06-30 $1.03B $6.39B 19.56%
2018-03-31 $0.77B $6.22B 16.30%
2017-12-31 $0.12B $4.27B 2.95%
2017-09-30 $0.02B $4.19B 0.40%
2017-06-30 $0.01B $4.14B 0.30%
2017-03-31 $0.03B $3.95B 0.64%
2016-12-31 $0.03B $3.85B 0.65%
2016-09-30 $0.09B $4.02B 2.45%
2016-06-30 $0.09B $3.88B 2.48%
2016-03-31 $0.10B $3.75B 2.81%
2015-12-31 $0.11B $3.71B 3.06%
2015-09-30 $0.10B $3.67B 2.94%
2015-06-30 $0.10B $3.53B 2.86%
2015-03-31 $0.10B $3.33B 2.99%
2014-12-31 $0.09B $3.34B 2.64%
2014-09-30 $0.08B $3.39B 2.37%
2014-06-30 $0.06B $3.47B 1.83%
2014-03-31 $0.07B $3.44B 1.91%
2013-12-31 $0.08B $3.39B 2.29%
2013-09-30 $0.09B $3.28B 2.66%
2013-06-30 $0.14B $3.48B 4.12%
2013-03-31 $0.15B $3.46B 4.61%
2012-12-31 $0.17B $3.44B 5.04%
2012-09-30 $0.18B $3.30B 5.71%
2012-06-30 $0.19B $3.17B 5.96%
2012-03-31 $0.18B $3.19B 5.76%
2011-12-31 $0.18B $3.10B 5.96%
2011-09-30 $0.19B $2.97B 6.24%
2011-06-30 $0.19B $3.04B 6.36%
2011-03-31 $0.18B $2.91B 6.58%
2010-12-31 $0.19B $3.06B 6.88%
2010-09-30 $0.16B $2.68B 6.06%
2010-06-30 $0.15B $2.53B 5.95%
2010-03-31 $0.15B $2.55B 6.06%
2009-12-31 $0.15B $2.54B 6.23%
2009-09-30 $0.10B $2.48B 4.49%
2009-06-30 $0.09B $2.34B 4.22%
2009-03-31 $0.09B $1.96B 4.59%
2008-12-31 $0.09B $2.04B 4.34%
2008-09-30 $0.11B $2.02B 5.36%
2008-06-30 $0.11B $2.10B 5.56%
2008-03-31 $0.09B $2.05B 4.98%
2007-12-31 $0.09B $1.97B 5.36%
2007-09-30 $0.10B $1.71B 5.97%
2007-06-30 $0.09B $1.66B 5.83%
2007-03-31 $0.10B $1.61B 6.37%
2006-12-31 $0.10B $1.60B 6.83%
2006-09-30 $0.10B $1.52B 6.76%
2006-06-30 $0.09B $1.49B 6.39%
2006-03-31 $0.08B $1.42B 5.51%
2005-12-31 $0.08B $1.43B 5.67%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.759B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.840B 28.17
Medtronic (MDT) Ireland $137.817B 19.69
Stryker (SYK) United States $81.180B 28.07
Boston Scientific (BSX) United States $58.714B 28.48
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $30.829B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.130B 18.00
Coloplast (CLPBY) Denmark $26.395B 42.14
Lonza Group Ag (LZAGY) Switzerland $26.038B 0.00
Terumo (TRUMY) Japan $23.788B 27.35
Smith & Nephew SNATS (SNN) United Kingdom $20.267B 0.00
ResMed (RMD) United States $19.315B 36.83
Sunny Optical Technology (SNPTF) China $13.689B 0.00
Canopy Growth (CGC) Canada $9.745B 0.00
Insulet (PODD) United States $9.055B 536.57
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Haemonetics (HAE) United States $7.033B 53.07
Hill-Rom Holdings (HRC) United States $7.032B 20.97
Perrigo (PRGO) Ireland $6.283B 11.57
Aurora Cannabis (ACB) Canada $6.094B 59.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.651B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.710B 61.70
ICU Medical (ICUI) United States $3.430B 22.25
NuVasive (NUVA) United States $3.316B 26.44
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.552B 25.34
Agios Pharmaceuticals (AGIO) United States $2.491B 0.00
National Vision Holdings (EYE) United States $2.177B 46.98
Cardiovascular Systems (CSII) United States $1.682B 0.00
Aphria (APHA) $1.551B 0.00
Phibro Animal Health (PAHC) United States $1.263B 18.92
AtriCure (ATRC) United States $1.060B 0.00
VAREX IMAGING (VREX) United States $1.018B 23.45
NanoString Technologies (NSTG) United States $0.977B 0.00
Omeros (OMER) United States $0.967B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.897B 23.57
Eagle Pharmaceuticals (EGRX) United States $0.794B 20.23
Cerus (CERS) United States $0.769B 0.00
MacroGenics (MGNX) United States $0.737B 0.00
Quanterix (QTRX) United States $0.702B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.626B 37.08
Surmodics (SRDX) United States $0.601B 114.26
OraSure Technologies (OSUR) United States $0.446B 20.63
Meridian Bioscience (VIVO) United States $0.432B 13.48
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.423B 0.00
BioLife Solutions (BLFS) United States $0.376B 123.63
United Health Products (UEEC) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.349B 25.56
Zynex (ZYXI) United States $0.345B 36.62
Owens & Minor (OMI) United States $0.306B 9.17
Bovie Medical (APYX) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Chimerix (CMRX) United States $0.153B 0.00
Fonar (FONR) United States $0.152B 8.01
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.123B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.087B 20.65
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Surface Oncology (SURF) United States $0.055B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00